Curanex Pharmaceuticals Inc Basic Shares Outstanding (Weighted Average)
Curanex Pharmaceuticals Inc (CURX) reported Basic Shares Outstanding (Weighted Average) of 28.36 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Curanex Pharmaceuticals Inc weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 28.36M shares, a 18.19% increase year-over-year.
- Curanex Pharmaceuticals Inc weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 28.34M shares, a 18.10% increase year-over-year.
- Curanex Pharmaceuticals Inc weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 28.37M shares, a 29.83% decline year-over-year.
- Curanex Pharmaceuticals Inc weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 25.60M shares, a 966.65% increase year-over-year.
- Curanex Pharmaceuticals Inc weighted average number of shares outstanding, basic for fiscal 2025 was 25.50M shares, a 92.30% increase from fiscal 2024.
- Curanex Pharmaceuticals Inc weighted average number of shares outstanding, basic for fiscal 2024 was 13.26M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 28.36M shares 10-Q · filed 2026-08-14 | 28.35M shares 10-Q · filed 2026-08-14 | 28.36M shares derived: average of 3 quarters · filed 2026-08-14 | 27.67M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 28.34M shares 10-Q · filed 2026-05-14 | 28.36M shares derived: average of 2 quarters · filed 2026-05-14 | 27.44M shares derived: average of 3 quarters · filed 2026-05-14 | 26.58M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | 28.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 26.99M shares derived: average of 2 quarters · filed 2026-03-30 | 25.99M shares derived: average of 3 quarters · filed 2026-08-14 | 25.50M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 25.60M shares 10-Q · filed 2025-11-17 | 24.80M shares derived: average of 2 quarters · filed 2026-08-14 | 24.54M shares 10-Q · filed 2025-11-17 | 28.51M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | 24.00M shares 10-Q · filed 2026-08-14 | 24.00M shares 10-Q · filed 2026-08-14 | 29.48M shares derived: average of 3 quarters · filed 2026-08-14 | 22.71M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | 24.00M shares 10-Q · filed 2026-05-14 | 32.22M shares derived: average of 2 quarters · filed 2026-05-14 | 22.28M shares derived: average of 3 quarters · filed 2026-05-14 | 17.31M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 40.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 21.42M shares derived: average of 2 quarters · filed 2026-03-30 | 15.08M shares derived: average of 3 quarters · filed 2026-03-30 | 13.26M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 2.40M shares 10-Q · filed 2025-11-17 | 2.40M shares derived: average of 2 quarters · filed 2025-11-17 | 4.20M shares 10-Q · filed 2025-11-17 | |
| 2024-06-30 | 2.40M shares 10-Q · filed 2025-09-09 | 2.40M shares 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |